Recent Updates
Recently added Catalysts
SDGR Positive Sentiment

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Key Takeaway: Schrödinger, Inc. announced the grant of restricted stock units (RSUs) to three new employees as part of its 2021 Inducement Equity Incentive Plan. These grants, totaling 2,243 shares, are intended to incentivize the acceptance of employment and will vest over four years. The decision was approved by the company's compensation committee.
Price reaction · baseline $23.93 (2026-09-16 close) · hit pre-market · clean, no other SDGR news in the window
day 0 close
+26.4%
day 1
+21.3%
day 3 · peak
+28.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Schrödinger is expanding its workforce with new hires.
  • The inducement grants are part of a strategic compensation plan.
  • The company's computational platform is well-regarded in drug development.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+15%
120-day peak, hindsight
Typical move
0.5%
average across 2 past catalysts
Cash runway
~34 mo
Minimal dilution risk

Full Press Release Details

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today reported that on September 13, 2026, the company granted restricted stock units (RSUs) with respect to 2,243 shares of the company’s common stock to three newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement to such employees’ acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.
The RSUs vest over four years, with 25 percent of such RSUs vesting when such employee completes 12 months of continuous service measured from the vesting commencement date, and the balance of the RSUs vesting in a series of successive equal yearly installments of 1/4 of the original number of RSUs upon each such employee’s completion of each additional year of service over the three-year period following the first anniversary of the vesting commencement date.
The inducement grants are subject to the terms and conditions of award agreements covering the grants and the company’s 2021 Inducement Equity Incentive Plan.
About Schrödinger
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs. To learn more, visit www.schrodinger.com , follow us on LinkedIn , or visit our blog, Extrapolations.com .
Matthew Luchini (Investors) Schrödinger, Inc. matthew.luchini@schrodinger.com 917-719-0636
Multimedia Files:

Frequently Asked Questions

What are the inducement grants by Schrödinger?

Schrödinger granted restricted stock units (RSUs) to new employees as part of their compensation.

How many shares were granted in the inducement?

A total of 2,243 shares were granted to three newly hired employees.

What is the vesting schedule for the RSUs?

The RSUs vest over four years, with 25% vesting after 12 months of service.

What plan governs these inducement grants?

The grants are made under Schrödinger's 2021 Inducement Equity Incentive Plan.

Last updated: Sep 17, 2026